Publications by authors named "Filip Krecak"

Claim this Profile
G
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia.
Ivan Krecak, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Filip Krecak

Leuk Lymphoma· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim.
Ivan Krečak, Ivana Skorić, Marina Čengić, Filip Krečak, Marko Skelin

Transfus Apher Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating YKL-40 in Philadelphia-negative myeloproliferative neoplasms.
Ivan Krečak, Velka Gverić-Krečak, Ivana Lapić, Pavle Rončević, Josipa Gulin

Acta Clin Belg· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms.
Ivan Krečak, Nena Peran, Ivana Lapić, Velka Gverić-Krečak, Filip Krečak

Wien Klin Wochenschr· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High red blood cell distribution width might predict thrombosis in essential thrombocythemia and polycythemia vera.
Ivan Krečak, Filip Krečak, Velka Gverić-Krečak

Blood Cells Mol Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum calprotectin: A circulating biomarker of the inflammatory state in Philadelphia-negative myeloproliferative neoplasms.
Ivan Krečak, Filip Krečak, Velka Gverić-Krečak, Iva Bilandžija, Pavle Rončević

Blood Cells Mol Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis